z-logo
open-access-imgOpen Access
When to Start ART in Africa — An Urgent Research Priority
Author(s) -
Kevin M. De Cock,
Wafaa ElSadr
Publication year - 2013
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmp1300458
Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , disease , antiretroviral treatment , intensive care medicine , family medicine , viral load , pathology
Proof of the prevention benefit of antiretroviral therapy (ART) raises questions about when to initiate ART in the course of HIV disease. But the effect of early initiation on morbidity and mortality is uncertain. A trial is required to determine when to initiate ART in Africa.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom